CJC‑1295 (No DAC) 5 mg is a high‑quality synthetic peptide widely used in laboratory and preclinical research centered on hormonal signaling, growth hormone release pathways, and cellular metabolism. As an analog of growth hormone‑releasing hormone (GHRH), CJC‑1295 (No DAC) stimulates the pituitary gland to enhance growth hormone (GH) secretion, helping researchers explore mechanisms of endocrine regulation, tissue repair, metabolic activity, and aging biology with precision.

Unlike CJC‑1295 with DAC (Drug Affinity Complex), the No DAC variant is designed for shorter‑acting release, supporting research protocols that require rapid receptor engagement and consistent pulsatile stimulation without extended half‑life properties. Its well‑characterized profile makes it ideal for controlled in‑vitro studies and preclinical models investigating GH dynamics, metabolic pathways, and endocrine responses.

Key Research Benefits:

• Stimulates growth hormone release: Engages pituitary GH pathways for metabolic and endocrine study.

• Short‑acting formulation: Designed for pulsatile research protocols without extended duration.

• Supports metabolic and recovery studies: Useful in exploring tissue growth signals and metabolic regulation.

• High‑purity performance: Lyophilized peptide with validated analytical quality supports reproducible results.

• Research versatility: Suitable for in‑vitro and preclinical investigations into hormonal dynamics.

Applications:

• Endocrine and hormonal signaling research

• Growth hormone release pathway studies

• Metabolic regulation and energy balance investigations

• Exploratory research on tissue repair and recovery processes

• Cellular signaling and receptor engagement studies

For research use only. Not intended for human or veterinary use.